alexa Gönül Hiçsönmez | OMICS International
ISSN: 2329-6917

Journal of Leukemia
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 

Gönül Hiçsönmez

Gönül Hiçsönmez Gönül Hiçsönmez
Professor
Hacettepe University 
Turkey

Biography

Prof. Dr. Gönül Hiçsönmez received her M.D. degree from Ankara University medical School in 1961. After graduating she went on to specialize in Pediatrics and Pediatric Hematology at Ihsan Doğramacı Children’s Hospital, Hacettepe University, Faculty of Medicine in Ankara. She has been honored with Professor degree at Hacettepe University in 1975. During her academic carier, her research interest has been focused mainly on the childhood hematologic malignancies. Since 1988, her research activity has concentrated on differentiation and apoptosis inducing therapy by using high-dose methylprednisolone, as a novel treatment approach in children with acute myeloblastic leukemia and myelodysplastic syndrome. She spent about a year between 1972 and 1973 in St. Jude Children’s Research Hospital. She continued to work at Hacettepe University until her retirement in 2004. Dr. Hiçsönmez has published more than 70 articles in the field of childhood hematologic malignancies. She was a member of different societies, and she spent great efforts to support the leukemic children as the head of the Children’s Leukemia Foundation at Hacettepe University between 1973 and 2004. Dr. Hiçsönmez has received Prof. Dr. Ihsan Doğramacı Scientific award in 1979 and research awards from the Hacettepe University Medical School in 1998 and award from Turkish Scientific and Technical Research Council (TUBÄ°TAK) in 1999.

Research Interest

Childhood Hematologic Malignancies, especially on Differentiation and Apoptosis inducing Therapy with High-dose Methylprednisolone in Children with Acute Myeloblastic Leukemia

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7